{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:44:36Z","timestamp":1770500676543,"version":"3.49.0"},"reference-count":173,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1053\/smrv.1999.0069","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T14:55:08Z","timestamp":1032447308000},"page":"57-99","source":"Crossref","is-referenced-by-count":90,"title":["Narcolepsy: genetic predisposition and neuropharmacological mechanisms"],"prefix":"10.1053","volume":"4","author":[{"given":"Seiji","family":"Nishino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsumi","family":"Okura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Mignot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/smrv.1999.0069_RF1","first-page":"626","volume":"53","year":"1880","journal-title":"Gazette des H\u00f4pitaux"},{"key":"10.1053\/smrv.1999.0069_RF2","article-title":"International classification of sleep disorders. Diagnostic and coding manual","author":"ICSD Chairman","year":"1990","journal-title":"Diagnostic Classification Steering Committee, Thorpy MJ, Rochester, MN: American Sleep Disorders"},{"key":"10.1053\/smrv.1999.0069_RF3","first-page":"S3","article-title":"Changes with age in severity of cataplexy and in sleep\/wake fragmentation in narcoleptic Doberman pinschers","volume":"22(S)","author":"Riehl","year":"1999","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF4","first-page":"171","article-title":"The clinical and polygraphic development of narcolepsy","author":"Billiard","year":"1983","journal-title":"In Guilleminault C, Lugaresi E (eds). Sleep\/wake disorders: natural history, epidemiology and longterm evolution. New York: Raven Press"},{"key":"10.1053\/smrv.1999.0069_RF5","first-page":"181","article-title":"Narcolepsy and ageing","author":"Sonka","year":"1991","journal-title":"In Smiru S, Frauceschi M, Ferini-Stambi L (eds). Sleep and Aging, Milano: Masson"},{"key":"10.1053\/smrv.1999.0069_RF6","first-page":"549","article-title":"Narcolepsy Syndrome","author":"Guilleminault","year":"1994","journal-title":"In Kryger MH, Roth R, Dement WC (eds). Principles and Practice of Sleep Medicine. Philadelphia: W. B. Saunders Company"},{"key":"10.1053\/smrv.1999.0069_RF7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1212\/WNL.46.2.393","article-title":"The clinical spectrum of narcolepsy and idiopathic hypersomnia","volume":"46","author":"Aldrich","year":"1996","journal-title":"Neurology"},{"key":"10.1053\/smrv.1999.0069_RF8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.410350612","article-title":"The prevalence of narcolepsy: an epidemiological study of the Finnish twin cohort","volume":"35","author":"Hublin","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1053\/smrv.1999.0069_RF9","volume":"13","author":"Tashiro","year":"1994","journal-title":"An epidemiological study of narcolepsy in Japanese. In: The 4th International Symposium on Narcolepsy; 1994; Tokyo, Japan"},{"key":"10.1053\/smrv.1999.0069_RF10","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.50.2_Suppl_1.S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50 (Suppl 1)","author":"Mignot","year":"1998","journal-title":"Neurology"},{"key":"10.1053\/smrv.1999.0069_RF11","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(89)91977-6","article-title":"Familial patterns of narcolepsy","volume":"335","author":"Guilleminault","year":"1989","journal-title":"Lancet"},{"key":"10.1053\/smrv.1999.0069_RF12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0301-0082(96)00070-6","article-title":"Pharmacological aspects of human and canine narcolepsy","volume":"52","author":"Nishino","year":"1997","journal-title":"Prog Neurobiol"},{"key":"10.1053\/smrv.1999.0069_RF13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0014-4886(82)90038-3","article-title":"Canine model of narcolepsy: genetic and developmental determinants","volume":"75","author":"Baker","year":"1982","journal-title":"Exp Neurol"},{"key":"10.1053\/smrv.1999.0069_RF14","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1073\/pnas.88.8.3475","article-title":"Genetic linkage of autosomal recessive canine narcolepsy with an immunoglobulin \u03bc chain switch-like segment","volume":"88","author":"Mignot","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/smrv.1999.0069_RF15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/vr.142.2.31","article-title":"The Stanford narcoleptic canine colony: twenty years of breeding history","volume":"142","author":"Cederberg","year":"1998","journal-title":"Vet Rec"},{"key":"10.1053\/smrv.1999.0069_RF16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/exnr.1998.6847","article-title":"Development of cataplexy in genetically narcoleptic Dobermans","volume":"152","author":"Riehl","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1053\/smrv.1999.0069_RF17","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1523\/JNEUROSCI.15-07-04806.1995","article-title":"Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of narcolepsy","volume":"15","author":"Nishino","year":"1995","journal-title":"J Neurosci"},{"key":"10.1053\/smrv.1999.0069_RF18","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1097\/00001756-199811160-00017","article-title":"Neuronal activity in the cholinoceptive basal forebrain of freely moving narcoleptic dobermans","volume":"9","author":"Nishino","year":"1998","journal-title":"Neuroreport"},{"key":"10.1053\/smrv.1999.0069_RF19","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1523\/JNEUROSCI.16-15-04588.1996","article-title":"Major histocompatibility class II molecules in the CNS: increased microglial expression at the onset of narcolepsy in a canine model","volume":"16","author":"Tafti","year":"1996","journal-title":"J Neurosci"},{"key":"10.1053\/smrv.1999.0069_RF20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1192\/bjp.169.4.459","article-title":"Hypnagogic and hypnopompic hallucinations: pathological phenomena?","volume":"169","author":"Ohayon","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1053\/smrv.1999.0069_RF21","first-page":"193","article-title":"Frequency of narcolepsy in the population of a French \u00ab\u00abDepartment\u00bb\u00bb","volume":"7 (Suppl 2)","author":"Ondze","year":"1998","journal-title":"J Sleep Res"},{"key":"10.1053\/smrv.1999.0069_RF22","article-title":"Narcolepsy and Hypersomnia.","author":"Roth","year":"1980","journal-title":"Basel: Karger"},{"key":"10.1053\/smrv.1999.0069_RF23","first-page":"147","article-title":"The prevalence of narcolepsy II","volume":"2","author":"Dement","year":"1973","journal-title":"Sleep Res"},{"key":"10.1053\/smrv.1999.0069_RF24","first-page":"179","article-title":"Narcolepsy in Negroes","volume":"6","author":"Solomon","year":"1945","journal-title":"Dis Nerv Sys"},{"key":"10.1053\/smrv.1999.0069_RF25","first-page":"191","article-title":"Census of narcolepsy, cataplexy and sleep life among teenagers in Fujisawa city","volume":"8","author":"Honda","year":"1979","journal-title":"Sleep Res"},{"key":"10.1053\/smrv.1999.0069_RF26","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/sleep\/10.6.608","article-title":"Narcolepsy is a rare disease in Israel","volume":"10","author":"Lavie","year":"1987","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF27","first-page":"631","article-title":"Eigenth\u00fcmliche mit Einschl\u00e4fen verbundene Anf\u00e4lle","volume":"7","author":"Westphal","year":"1877","journal-title":"Arch Psychiat"},{"key":"10.1053\/smrv.1999.0069_RF28","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1093\/sleep\/17.suppl_8.S54","article-title":"Family studies in narcolepsy","volume":"17(Suppl)","author":"Billiard","year":"1994","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF29","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/sleep\/17.suppl_8.S25","article-title":"Postraumatic narcolepsy in mild to moderate closed head injury","volume":"17","author":"Lankford","year":"1994","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF30","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/sleep\/17.suppl_8.S50","article-title":"Life events in the year preceding the onset of narcolepsy","volume":"17","author":"Orellana","year":"1994","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0065-2776(08)60753-1","article-title":"Molecular basis of human leukocyte antigen class II disease associations","volume":"48","author":"Charron","year":"1990","journal-title":"Adv Immunol"},{"key":"10.1053\/smrv.1999.0069_RF32","first-page":"360","article-title":"Positive DR2 as a prerequisite for the development of narcolepsy","volume":"38","author":"Honda","year":"1984","journal-title":"Folia Psychiatr Neurol Jpn"},{"key":"10.1053\/smrv.1999.0069_RF33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/978-3-642-83387-8_4","article-title":"HLA in Narcolepsy in Japan","author":"Matsuki","year":"1988","journal-title":"In Honda Y, Juji T (eds). HLA in Narcolepsy. Berlin: Springer-Verlag"},{"key":"10.1053\/smrv.1999.0069_RF34","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(84)92742-9","article-title":"Genetic markers in Narcolepsy","volume":"2","author":"Langdon","year":"1984","journal-title":"Lancet"},{"key":"10.1053\/smrv.1999.0069_RF35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/sleep\/9.1.149","article-title":"HLA-DR2 and narcolepsy","volume":"9","author":"Billiard","year":"1986","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF36","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/WNL.37.12.1858","article-title":"HLA antigens in narcolepsy","volume":"37","author":"Neely","year":"1987","journal-title":"Neurology"},{"key":"10.1053\/smrv.1999.0069_RF37","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0140-6736(92)90571-J","article-title":"DQ rather than DR gene marks susceptibility to narcolepsy","volume":"339","author":"Matsuki","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/smrv.1999.0069_RF38","first-page":"217","article-title":"Genetic aspects of narcolepsy","author":"Honda","year":"1990","journal-title":"In Thropy M (ed). Handbook of sleep disorder. New York: Marcel Dekker, Inc."},{"key":"10.1053\/smrv.1999.0069_RF39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-0039.1986.tb00476.x","article-title":"HLA and narcolepsy in a German population","volume":"28","author":"Mueller-Eckardt","year":"1986","journal-title":"Tissue Antigens"},{"key":"10.1053\/smrv.1999.0069_RF40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-642-83387-8_7","article-title":"HLA in Narcolepsy in Canada","author":"Montplaisir","year":"1988","journal-title":"In Honda Y, Juji T (eds). HLA in Narcolepsy. Berlin: Springer-Verlag"},{"key":"10.1053\/smrv.1999.0069_RF41","first-page":"41","article-title":"A study of occurrence of HLA DR2 in 124 narcoleptics: clinical aspects","volume":"139","author":"Roth","year":"1988","journal-title":"Arch Suiss Neurol et de Psychiat"},{"key":"10.1053\/smrv.1999.0069_RF42","first-page":"217","article-title":"Genetic aspects of narcolepsy","author":"Honda","year":"1990","journal-title":"In Thorpy M (ed). Handbook of sleep disorder. New York: Marcel Dekker, Inc"},{"key":"10.1053\/smrv.1999.0069_RF43","first-page":"1012","article-title":"HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients","volume":"20","author":"Mignot","year":"1997","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF44","first-page":"333","article-title":"Analysis of HLA class II genes by single-strand conformation polymorphisms in narcolepsy","author":"Lin","year":"1992","journal-title":"In Tsuji K, Aizawa M, Sasasuki T (eds). HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. New York: Oxford University Press"},{"key":"10.1053\/smrv.1999.0069_RF45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0198-8859(95)00106-9","article-title":"HLA class II analysis in Jewish Israeli narcoleptic patients","volume":"44","author":"Kwon","year":"1995","journal-title":"Hum Immunol"},{"key":"10.1053\/smrv.1999.0069_RF46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1399-0039.1995.tb02503.x","article-title":"The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele","volume":"46","author":"Fogdell","year":"1995","journal-title":"Tissue Antigens"},{"key":"10.1053\/smrv.1999.0069_RF47","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/sleep\/17.suppl_8.S60","article-title":"DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in caucasian and black Americans","volume":"17","author":"Mignot","year":"1994","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00211994","article-title":"Alelles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethnic groups","volume":"34","author":"Fernandez-vina","year":"1991","journal-title":"Immunogenetics"},{"key":"10.1053\/smrv.1999.0069_RF49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1399-0039.1991.tb01904.x","article-title":"HLA class II haplotypes in Amerindians and in black North and South Americans","volume":"38","author":"Fernandez-Vina","year":"1991","journal-title":"Tissue Antigens"},{"key":"10.1053\/smrv.1999.0069_RF50","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1399-0039.1997.tb02907.x","article-title":"DQ microsatellite association studies in three ethnic groups","volume":"50","author":"Lin","year":"1997","journal-title":"Tissue Antigens"},{"key":"10.1053\/smrv.1999.0069_RF51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4049\/jimmunol.148.1.249","article-title":"Polymorphism, recombination, and linkage disequilibrium within the HLA class II region","volume":"148","author":"Begovich","year":"1992","journal-title":"J Immunol"},{"key":"10.1053\/smrv.1999.0069_RF52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1399-0039.1997.tb02761.x","article-title":"Extensive HLA Class II studies in 58 non DRB!*15 (DR2) narcoleptic patients with cataplexy","volume":"49","author":"Mignot","year":"1997","journal-title":"Tissue Antigens"},{"key":"10.1053\/smrv.1999.0069_RF53","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s002510050295","article-title":"HLA class II haplotype and sequence analysis support a role of DQ in narcolepsy","volume":"46","author":"Ellis","year":"1997","journal-title":"Immunogenetics"},{"key":"10.1053\/smrv.1999.0069_RF54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1399-0039.1998.tb02952.x","article-title":"HLA-DQB1*0602 homozygosity increases relative risk for narcolepsy but not disease severity in two ethnic groups","volume":"51","author":"Pelin","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1053\/smrv.1999.0069_RF55","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(05)78496-8","article-title":"Reduction of REM sleep latency associated with HLA-DQB1*0602 in normal adults","volume":"351","author":"Mignot","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/smrv.1999.0069_RF56","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(86)90314-4","article-title":"HLA-DR2 correlates with rapid-eye-movement sleep latency in normal human subjects","volume":"2","author":"Schulz","year":"1986","journal-title":"Lancet"},{"key":"10.1053\/smrv.1999.0069_RF57","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1399-0039.1997.tb02761.x","article-title":"Extensive HLA Class II studies in 58 non DRB1*15(DR2) narcoleptic patients with cataplexy","volume":"49","author":"Mignot","year":"1997","journal-title":"Tissue Antigens"},{"key":"10.1053\/smrv.1999.0069_RF58","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/sleep\/15.5.415","article-title":"DQB1-0602 (DQwl) is not present in most non-DR2 caucasian narcoleptics","volume":"15","author":"Mignot","year":"1992","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF59","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.50.2_Suppl_1.S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50 (Suppl 1)","author":"Mignot","year":"1998","journal-title":"Neurology"},{"key":"10.1053\/smrv.1999.0069_RF60","first-page":"433","article-title":"HLA Class II studies in 509 narcoleptic patients","volume":"26","author":"Mignot","year":"1997","journal-title":"Sleep Res"},{"key":"10.1053\/smrv.1999.0069_RF61","first-page":"S121","article-title":"Identification of a novel HLA narcolepsy susceptibility subtype, HLA-DQB1*0301","volume":"22","author":"Mignot","year":"1999","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF62","first-page":"29","article-title":"Is narcolepsy an autoimmune disease?","author":"Mignot","year":"1992","journal-title":"In Smirne S, Francesci M, Ferini-Strambi L, Zucconi M (eds). Proceedings of the Third Milano International Symposium, September 18\u201319 \u00ab\u00abSleep, Hormones, and the Immune System\u00bb\u00bb. Milan: Masson"},{"key":"10.1053\/smrv.1999.0069_RF63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0404.1990.tb00978.x","article-title":"CSF immune variable in patients with narcolepsy","volume":"81","author":"Frederickson","year":"1990","journal-title":"Acta Neurol Scand"},{"key":"10.1053\/smrv.1999.0069_RF64","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/978-3-642-83387-8_13","article-title":"Immunological features of narcolepsy in Japan","author":"Matsuki","year":"1988","journal-title":"In Honda Y, Juji T (eds). HLA in Narcolepsy. Berlin: Spinger-Verlag"},{"key":"10.1053\/smrv.1999.0069_RF65","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1523\/JNEUROSCI.13-03-01057.1993","article-title":"Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems","volume":"13","author":"Mignot","year":"1993","journal-title":"J Neurosci"},{"key":"10.1053\/smrv.1999.0069_RF66","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/107385849800400209","article-title":"Neurobiology of Narcolepsy","volume":"4","author":"Nishino","year":"1998","journal-title":"Neuroscientist"},{"key":"10.1053\/smrv.1999.0069_RF67","first-page":"1052","article-title":"Narcolepsy in a dog and a cat","volume":"162","author":"Knecht","year":"1973","journal-title":"J Am Vet Med Assoc"},{"key":"10.1053\/smrv.1999.0069_RF68","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0014-4886(74)90122-8","article-title":"Narcolepsy\u2013cataplexy in a female dog","volume":"45","author":"Mitler","year":"1974","journal-title":"Exp Neurol"},{"key":"10.1053\/smrv.1999.0069_RF69","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/978-3-642-83387-8_3","article-title":"Clinical features of narcolepsy","author":"Honda","year":"1988","journal-title":"In Honda Y, Juji T (eds). HLA in narcolepsy. Berlin: Springer-Verlag"},{"key":"10.1053\/smrv.1999.0069_RF70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0198-8859(89)90067-0","article-title":"Narcolepsy without unique MHC class II antigen association: Studies in the canine model","volume":"25","author":"Dean","year":"1989","journal-title":"Hum Immunol"},{"key":"10.1053\/smrv.1999.0069_RF71","first-page":"A112","article-title":"Establishing FISH methodology to study synthetic regions between canine and human chromosomes","volume":"57","author":"Dutra","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1053\/smrv.1999.0069_RF72","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jhered\/90.1.129","article-title":"Genetic studies in narcolepsy, a disorder of REM sleep","volume":"90","author":"Faraco","year":"1999","journal-title":"J Heredity"},{"key":"10.1053\/smrv.1999.0069_RF73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/geno.1999.5772","article-title":"Construction and characterization of an eight fold redundant dog genomic bacterial artificial chromosome library","volume":"58","author":"Li","year":"1999","journal-title":"Genomics"},{"key":"10.1053\/smrv.1999.0069_RF74","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/sleep\/9.1.194","article-title":"Alerting effects of naps in patients with narcolepsy","volume":"9","author":"Roehrs","year":"1986","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF75","first-page":"235","article-title":"Treatment of narcolepsy","author":"Thorpy","year":"1990","journal-title":"In Thorpy MJ (ed.). Handbook of Sleep Disorders. New York: Marcel Dekker, Inc"},{"key":"10.1053\/smrv.1999.0069_RF76","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/sleep\/16.5.444","article-title":"Scheduled naps in the management of daytime sleepiness in narcolepsy\u2013cataplexy","volume":"16","author":"Mullington","year":"1993","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF77","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01376517-198412000-00009","article-title":"Problems and coping strategies identified by narcoleptic patients","volume":"16","author":"Rogers","year":"1984","journal-title":"J Neurosurg Nursing"},{"key":"10.1053\/smrv.1999.0069_RF78","first-page":"1","article-title":"Stimulant medication survey","author":"American Narcolepsy Association","year":"1992","journal-title":"The Eye Opener"},{"key":"10.1053\/smrv.1999.0069_RF79","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/sleep\/17.4.348","article-title":"Practice parameters for the use of stimulants in the treatment of narcolepsy","volume":"17","author":"American Sleep Disorders Association","year":"1994","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF80","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1001\/jama.1935.02760510023006","article-title":"The use of benzedrine for the treatment of narcolepsy","volume":"105","author":"Prinzmetal","year":"1935","journal-title":"JAMA"},{"key":"10.1053\/smrv.1999.0069_RF81","first-page":"339","article-title":"The comparative physiological actions of d 1-beta-phenylisopropylamines: pressor effects and toxicity","volume":"47","author":"Alles","year":"1933","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1053\/smrv.1999.0069_RF82","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/jnnp.36.6.1076","article-title":"Levo(\u2212)amphetamine and dextro(+)amphetamine in the treatment of narcolepsy","volume":"36","author":"Parkes","year":"1973","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/smrv.1999.0069_RF83","first-page":"459","article-title":"Amphetamines and other drugs","author":"Parkes","year":"1985","journal-title":"In: Sleep and its disorders. London: W.B. Saunders Company"},{"key":"10.1053\/smrv.1999.0069_RF84","first-page":"383","article-title":"Differential effects of D- and L-amphetamine isomers on dopaminergic transmission: Implication for the control of alertness in canine narcolepsy","volume":"26","author":"Kanbayashi","year":"1997","journal-title":"Sleep Res"},{"key":"10.1053\/smrv.1999.0069_RF85","first-page":"643","article-title":"Amphetamines and alertness","author":"Parkes","year":"1976","journal-title":"In Guilleminault C, Dement WC, Passouant P (eds). Narcolepsy. New York: Spectrum publication"},{"key":"10.1053\/smrv.1999.0069_RF86","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1212\/WNL.9.3.171","article-title":"Treatment of narcolepsy with ritalin","volume":"9","author":"Yoss","year":"1959","journal-title":"Neurology"},{"key":"10.1053\/smrv.1999.0069_RF87","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00005053-199501000-00009","article-title":"Psychiatric morbidity in narcoleptics on chronic high doses methylphenidate therapy","volume":"183","author":"Pawluk","year":"1995","journal-title":"J Nerv Ment Dis"},{"key":"10.1053\/smrv.1999.0069_RF88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/sleep\/20.1.28","article-title":"Compliance with stimulant medications in patients with Narcolepsy","volume":"20","author":"Rogers","year":"1996","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF89","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/sleep\/9.1.265","article-title":"Therapeutic effects of mazindol on narcolepsy","volume":"9","author":"Iijima","year":"1986","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF90","first-page":"49","article-title":"Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants","volume":"1","author":"Nishino","year":"1998","journal-title":"Sleep Research Online"},{"key":"10.1053\/smrv.1999.0069_RF91","first-page":"352","article-title":"Narcolepsy and its treatment with stimulants","volume":"17","author":"Miler","year":"1994","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF92","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0028-3908(69)90077-X","article-title":"Electroencephalographic analyses of amphetamine and its methoxy derivatives with reference to their sites of EEG alerting in the rabbit brain","volume":"8","author":"Fujimori","year":"1969","journal-title":"Int J Neuropharmac"},{"key":"10.1053\/smrv.1999.0069_RF93","first-page":"159","article-title":"Metamphetamine psychosis","author":"Seijun","year":"1970","journal-title":"In Ellinwood EH, Cohen S (eds). Current Concept on Amphetamine Abuse. Rockville, Naryland: National Institute of Mental Health"},{"key":"10.1053\/smrv.1999.0069_RF94","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0278-5846(88)90014-0","article-title":"Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil","volume":"12","author":"Bastuji","year":"1988","journal-title":"Prog Neuropsychopharmacol Biol Psychiat"},{"key":"10.1053\/smrv.1999.0069_RF95","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0987-7053(05)80282-5","article-title":"Effect du modafinil (300 mg) sur le sommeil, la somnolence et la vigilance du narcoleptique","volume":"23","author":"Besset","year":"1993","journal-title":"Neurophysiol Clin"},{"key":"10.1053\/smrv.1999.0069_RF96","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00002826-199302000-00005","article-title":"Effect of modafinil on symptomatology of human narcolepsy","volume":"16","author":"Boivin","year":"1993","journal-title":"Clin Neuropharmacol"},{"key":"10.1053\/smrv.1999.0069_RF97","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.410430115","article-title":"Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy","volume":"43","author":"US modafinil in narcolepsy multicenter study group","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1053\/smrv.1999.0069_RF98","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.49.2.444","article-title":"Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy","volume":"49","author":"Broughton","year":"1997","journal-title":"Neurology"},{"key":"10.1053\/smrv.1999.0069_RF99","first-page":"336","article-title":"Modafinil for the treatment of excessive daytime sleepiness in narcolepsy: a double-blind, placebo-controlled, cross-over trial","volume":"26","author":"Brougton","year":"1998","journal-title":"Sleep Research"},{"key":"10.1053\/smrv.1999.0069_RF100","first-page":"825","article-title":"Lack of cardiovascular effects after administration of modafinil in conscious monkeys","author":"Hermant","year":"1991","journal-title":"In French Association des Pharmacologistes Tours; 1991. Fundam Clin Pharmacol"},{"key":"10.1053\/smrv.1999.0069_RF101","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF02247379","article-title":"Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil","volume":"126","author":"Gold","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1053\/smrv.1999.0069_RF102","first-page":"S1:362","article-title":"Modafinil promotes EEG wake without intensifying motor activity in the rat","volume":"72","author":"Edgar","year":"1994","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1053\/smrv.1999.0069_RF103","first-page":"345","article-title":"Central nervous system stimulants","author":"Rall","year":"1985","journal-title":"In Gilman AG, Goodman LS, Rall TW, Murad F (eds). The Pharmacological Basis of Therapeutics, 7th edn. New York: Pergamon Press"},{"key":"10.1053\/smrv.1999.0069_RF104","first-page":"704","article-title":"Pharmacotherapy in narcolepsy","volume":"21","author":"Akimoto","year":"1960","journal-title":"Dis Nerv Sys"},{"key":"10.1053\/smrv.1999.0069_RF105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00212777","article-title":"Effects of protriptyline on vigilance and information processing in narcolepsy","volume":"95","author":"Henry","year":"1988","journal-title":"Psychopharmacol"},{"key":"10.1053\/smrv.1999.0069_RF106","first-page":"669","article-title":"Polygraphic aspects of narcolepsy","author":"Raynal","year":"1976","journal-title":"In Guillemault CWCD, Passouant P (eds). Narcolepsy. New York: Spectrum publications, Inc."},{"key":"10.1053\/smrv.1999.0069_RF107","first-page":"243","article-title":"How do antidepressants work?","author":"Baldessarini","year":"1983","journal-title":"In Davis JM, Mass JW (eds). The Affective Disorders. Washington, D.C.: American Psychiatric Press"},{"key":"10.1053\/smrv.1999.0069_RF108","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/sleep\/9.2.371","article-title":"Fluoxetine in the treatment of cataplexy","volume":"9","author":"Langdon","year":"1986","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF109","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/sleep\/9.1.280","article-title":"Serotonergic reuptake mechanisms in the control of cataplexy","volume":"9","author":"Montplaisir","year":"1986","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1600-0404.1986.tb03518.x","article-title":"The treatment of accessory symptoms in narcolepsy: a double-blind cross-over study of a selective serotonin re-uptake inhibitor (femoxetine) versus placebo","volume":"74","author":"Schrader","year":"1986","journal-title":"Acta Neurol Scand"},{"key":"10.1053\/smrv.1999.0069_RF111","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0022-510X(66)90001-3","article-title":"Treatment of narcolepsy with imipramine (tofranil) and desmethylimipramine (pertofran)","volume":"3","author":"Hishikawa","year":"1965","journal-title":"J Neuro Sci"},{"key":"10.1053\/smrv.1999.0069_RF112","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/sleep\/9.1.260","article-title":"Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline","volume":"9","author":"Mitler","year":"1986","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF113","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0404.1976.tb07621.x","article-title":"Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride","volume":"54","author":"Guilleminault","year":"1976","journal-title":"Acta Neurol Scand"},{"key":"10.1053\/smrv.1999.0069_RF114","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archneur.1975.00490520023002","article-title":"Treatment of cataplexy with clomipramine","volume":"32","author":"Shapiro","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1053\/smrv.1999.0069_RF115","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/sleep\/16.8.706","article-title":"Desmethyl metabolites of serotonergic uptake inhibitors are more potent for suppressing canine cataplexy than their parent compounds","volume":"16","author":"Nishino","year":"1993","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF116","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1136\/jnnp.43.2.171","article-title":"Fluvoxamine and clomipramine in the treatment of cataplexy","volume":"43","author":"Schachter","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/smrv.1999.0069_RF117","first-page":"304","article-title":"Improvement in cataplexy with yohimbine and paroxetine: case report","volume":"23","author":"Poceta","year":"1994","journal-title":"Sleep Res"},{"key":"10.1053\/smrv.1999.0069_RF118","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/sleep\/9.1.275","article-title":"Viloxazine hydrochloride in narcolepsy: a preliminary report","volume":"9","author":"Guilleminault","year":"1986","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF119","first-page":"79","article-title":"New treatment for narcolepsy (viloxazine)","author":"Godbout","year":"1988","journal-title":"In Burton SA, Dement WC, Ristanovic R (eds). Narcolepsy, 3rd International Symposium, 1988. San Diego"},{"key":"10.1053\/smrv.1999.0069_RF120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF02244337","article-title":"Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers","volume":"113","author":"Mignot","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1053\/smrv.1999.0069_RF121","first-page":"217","article-title":"Venlafaxine in the treatment of the narcoleptic syndrome","volume":"5 (Suppl 1)","author":"Smith","year":"1996","journal-title":"J Sleep Res"},{"key":"10.1053\/smrv.1999.0069_RF122","first-page":"625","article-title":"The action of tricyclics (alone or in combination with methylphenidate) upon several symptoms of narcolepsy","author":"Takahashi","year":"1976","journal-title":"In Guilleminault C, Dement WC, Passouant P (eds). Narcolepsy. New York: Spectrum Publications"},{"key":"10.1053\/smrv.1999.0069_RF123","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0033-3182(93)71913-1","article-title":"Fluoxetine for isolated sleep paralysis","volume":"34","author":"Koran","year":"1993","journal-title":"Psychomatics"},{"key":"10.1053\/smrv.1999.0069_RF124","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/sleep\/9.1.285","article-title":"Treatment of narcolepsy with \u03b3-hydroxybutyrate. A review of clinical and sleep laboratory findings","volume":"9","author":"Mamelak","year":"1986","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF125","first-page":"380","article-title":"Acute poisoning from gammahydroxybutyrate in California","volume":"156","author":"Chin","year":"1992","journal-title":"West J Med"},{"key":"10.1053\/smrv.1999.0069_RF126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00002826-198902000-00004","article-title":"Nocturnal \u03b3-hydroxybutyrate","volume":"12","author":"B\u00e9dard","year":"1989","journal-title":"Clin Neuropharmacol"},{"key":"10.1053\/smrv.1999.0069_RF127","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/sleep\/9.1.116","article-title":"Sleep fragmentation in genetically narcoleptic dogs","volume":"9","author":"Kaitin","year":"1986","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF128","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1093\/sleep\/17.suppl_8.S84","article-title":"Neuropharmacology and neurochemistry of canine narcolepsy","volume":"17","author":"Nishino","year":"1994","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF129","first-page":"125","article-title":"Cataplexy","author":"Guilleminault","year":"1976","journal-title":"Narcolepsy (Advances in Sleep Research Vol. 3)"},{"key":"10.1053\/smrv.1999.0069_RF130","first-page":"125","article-title":"Brainstem mechanisms generating REM sleep","author":"Siegel","year":"1994","journal-title":"In Kryger MH, Roth T, Dement WC (eds). Principles and Practice of Sleep Medicine. Philadelphia: W.B. Saunders Company"},{"key":"10.1053\/smrv.1999.0069_RF131","first-page":"199","article-title":"Canine narcolepsy\u2013cataplexy syndrome: evidence for an inherited monoaminergic\u2013cholinergic imbalance","author":"Baker","year":"1985","journal-title":"In McGinty DJ, Drucker-Colin R, Morrison A, Parmeggiani PL (eds). Brain Mechanisms of Sleep. New York: Raven Press"},{"key":"10.1053\/smrv.1999.0069_RF132","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0006-8993(79)90157-4","article-title":"Raphe unit activity in freely moving cats: Correlation with level of behavioral arousal","volume":"163","author":"Trulson","year":"1979","journal-title":"Brain Res"},{"key":"10.1053\/smrv.1999.0069_RF133","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1523\/JNEUROSCI.01-08-00876.1981","article-title":"Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep\u2013waking cycle","volume":"1","author":"Aston-Jones","year":"1981","journal-title":"J Neurosci"},{"key":"10.1053\/smrv.1999.0069_RF134","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0006-8993(83)91101-0","article-title":"Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and waking in the rat","volume":"273","author":"Miller","year":"1983","journal-title":"Brain Res"},{"key":"10.1053\/smrv.1999.0069_RF135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0304-3940(81)90346-3","article-title":"Activity of substantia nigra units across the sleep\u2013waking cycle in freely moving cats","volume":"26","author":"Trulson","year":"1981","journal-title":"Neurosci Lett"},{"key":"10.1053\/smrv.1999.0069_RF136","first-page":"91","article-title":"The pharmacokinetics of antidepressant drugs: relevance to their therapeutic effect","author":"Peet","year":"1979","journal-title":"In Paykel ES, Coppen A (eds). Psychopharmacology of Affective Disorders. Oxford: Oxford University Press"},{"key":"10.1053\/smrv.1999.0069_RF137","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/ajp.134.2.183","article-title":"Protriptyline: an effective agent in the treatment of narcolepsy\u2013cataplexy syndrome and hypersomnia","volume":"134","author":"Schmidt","year":"1977","journal-title":"Am J Psychiatry"},{"key":"10.1053\/smrv.1999.0069_RF138","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00004691-199001000-00008","article-title":"Narcolepsy","volume":"7","author":"Mitler","year":"1990","journal-title":"J Clin Neurophysiol"},{"key":"10.1053\/smrv.1999.0069_RF139","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0924-977X(97)00418-5","article-title":"Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodes","volume":"7 (Suppl 1)","author":"Berzewski","year":"1997","journal-title":"Eur Neuropsychopharmacology"},{"key":"10.1053\/smrv.1999.0069_RF140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0006-2952(78)90300-3","article-title":"Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin-comparison of fluoxetine and chlorimipramine","volume":"27","author":"Fuller","year":"1977","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/smrv.1999.0069_RF141","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0024-3205(79)90126-7","article-title":"The central stimulatory action of inhibitors of dopamine uptake","volume":"24","author":"Ross","year":"1979","journal-title":"Life Sci"},{"key":"10.1053\/smrv.1999.0069_RF142","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-3-642-67538-6_21","article-title":"Biochemical effects of antidepressants in animals","author":"Sulser","year":"1980","journal-title":"In Hoffmeister F, Stille G (eds). Psychotropic Agent: Antipsychotics and Antidepressants, Handbook of Experimental Pharmacology. Berlin: Springer\u2013Verlag"},{"key":"10.1053\/smrv.1999.0069_RF143","first-page":"1079","article-title":"Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsy","volume":"264","author":"Nishino","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1053\/smrv.1999.0069_RF144","first-page":"1145","article-title":"Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep","volume":"253","author":"Nishino","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1053\/smrv.1999.0069_RF145","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1523\/JNEUROSCI.11-09-02666.1991","article-title":"Dopamine D2 mechanisms in canine narcolepsy","volume":"11","author":"Nishino","year":"1991","journal-title":"J Neurosci"},{"key":"10.1053\/smrv.1999.0069_RF146","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-8993(96)00541-0","article-title":"Local administration of dopaminergic drugs into the ventral tegmental area modulate cataplexy in the narcoleptic canine","volume":"733","author":"Reid","year":"1996","journal-title":"Brain Res"},{"key":"10.1053\/smrv.1999.0069_RF147","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(89)90315-6","article-title":"Canine narcolepsy is associated with an elevated number of \u03b12receptors in the locus coeruleus","volume":"500","author":"Fruhstorfer","year":"1989","journal-title":"Brain Res"},{"key":"10.1053\/smrv.1999.0069_RF148","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0006-8993(87)91045-6","article-title":"Brain dopamine receptor levels elevated in canine narcolepsy","volume":"402","author":"Bowersox","year":"1987","journal-title":"Brain Res"},{"key":"10.1053\/smrv.1999.0069_RF149","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/0024-3205(84)90675-1","article-title":"Narcolepsy: cholinergic receptor changes in an animal model","volume":"34","author":"Boehme","year":"1984","journal-title":"Life Sci"},{"key":"10.1053\/smrv.1999.0069_RF150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF00167378","article-title":"The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra","volume":"344","author":"Nissbrandt","year":"1991","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1053\/smrv.1999.0069_RF151","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0031-9384(70)90061-2","article-title":"A pharmacological model of paradoxical sleep: the role of cholinergic and monoaminergic systems","volume":"5","author":"Kraczmar","year":"1970","journal-title":"Physiol Behav"},{"key":"10.1053\/smrv.1999.0069_RF152","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0306-4522(94)90174-0","article-title":"Cholinergic mechanisms in canine narcolepsy: II. Acetylcholine release in the potine reticular formation is enhanced during cataplexy","volume":"59","author":"Reid","year":"1994","journal-title":"Neuroscience"},{"key":"10.1053\/smrv.1999.0069_RF153","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0306-4522(94)90173-2","article-title":"Cholinergic mechanisms in canine narcolepsy: I. Modulation of cataplexy via local drug administration into pontine reticular formation","volume":"59","author":"Reid","year":"1994","journal-title":"Neuroscience"},{"key":"10.1053\/smrv.1999.0069_RF154","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1523\/JNEUROSCI.13-01-00229.1993","article-title":"Simultaneous pontine and basal forebrain microinjection of carbachol suppresses REM sleep","volume":"13","author":"Baghdoyan","year":"1993","journal-title":"J Neurosci"},{"key":"10.1053\/smrv.1999.0069_RF155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0006-8993(79)90010-6","article-title":"The latency of activation of neurones in the lateral hypothalamus and substantia innominata during feeding in the monkey","volume":"1654","author":"Rolls","year":"1979","journal-title":"Brain Res"},{"key":"10.1053\/smrv.1999.0069_RF156","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/exnr.1998.6787","article-title":"Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcokleptic canines","volume":"151","author":"Reid","year":"1998","journal-title":"Exp Neurology"},{"key":"10.1053\/smrv.1999.0069_RF157","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1212\/WNL.39.11.1505","article-title":"Narcolepsy associated with lesions of the diencephalon","volume":"39","author":"Aldrich","year":"1989","journal-title":"Neurology"},{"key":"10.1053\/smrv.1999.0069_RF158","first-page":"317","article-title":"Differential effects of dopaminergic and noradrenergic uptake inhibitors on EEG arousal and cataplexy of narcoleptic canines","volume":"25","author":"Nishino","year":"1996","journal-title":"Sleep Res"},{"key":"10.1053\/smrv.1999.0069_RF159","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/sleep\/17.5.436","article-title":"Modafinil binds to the dopamine uptake carrier site with low affinity","volume":"17","author":"Mignot","year":"1994","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-4886(76)90279-X","article-title":"Effects of caudate nuclei or frontal cortex ablations in cats. II. Sleep\u2013wakefulness, EEG, and motor activity","volume":"53","author":"Villablanca","year":"1976","journal-title":"Exper Neurol"},{"key":"10.1053\/smrv.1999.0069_RF161","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.948760","article-title":"Manoamine changes in the brain of cats during slow-wave sleep","volume":"193","author":"Kovacevic","year":"1976","journal-title":"Science"},{"key":"10.1053\/smrv.1999.0069_RF162","first-page":"145","article-title":"Basic mechanisms of sleep\u2013wake states","author":"Jones","year":"1994","journal-title":"In Kryger MH, Roth T, Dement WC (eds). Principles and Practice of Sleep Medicine. Philadelphia: W.B. Saunders Company"},{"key":"10.1053\/smrv.1999.0069_RF163","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.274.5290.1211","article-title":"Neuronal gene expression in the waking state: a role for the locus coeruleus","volume":"274","author":"Cirelli","year":"1996","journal-title":"Science"},{"key":"10.1053\/smrv.1999.0069_RF164","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0361-9230(85)90140-6","article-title":"Simultaneous recording of substantia nigra neurons and voltametric release of dopamine in the caudate of behaving cats","volume":"15","author":"Trulson","year":"1985","journal-title":"Brain Res Bull"},{"key":"10.1053\/smrv.1999.0069_RF165","first-page":"576","article-title":"Catecholamines in neocortex of rhesus monkeys: regional distribution and ontogenetic development","volume":"142","author":"Brown","year":"1977","journal-title":"rain Res"},{"key":"10.1053\/smrv.1999.0069_RF166","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00314781","article-title":"Nocturnal sleep in Huntington's disease","volume":"238","author":"Wiegand","year":"1991","journal-title":"J Neurol"},{"key":"10.1053\/smrv.1999.0069_RF167","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1097\/00001756-199911260-00046","article-title":"Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep","volume":"10","author":"Honda","year":"1999","journal-title":"Neuroreport"},{"key":"10.1053\/smrv.1999.0069_RF168","first-page":"S1","article-title":"Roles of diencephalic dopaminergic cell groups in regulation of cataplexy in canine narcolepsy","volume":"22S","author":"Okura","year":"1999","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF169","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1476-5381.1988.tb11715.x","article-title":"Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats","volume":"95","author":"Bagetta","year":"1988","journal-title":"Br J Pharmacol"},{"key":"10.1053\/smrv.1999.0069_RF170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archpsyc.1960.01710040091011","article-title":"Studies in psychophysiology of dreams III. The dream of narcolepsy","volume":"3","author":"Vogel","year":"1960","journal-title":"Arch Gen Psychiatry"},{"key":"10.1053\/smrv.1999.0069_RF171","first-page":"s2","article-title":"REM sleep, but not cataplexy, is controlled by a 30-minute normal ultradian rhythm in narcoleptic canines","author":"Nishino","year":"1999","journal-title":"Sleep"},{"key":"10.1053\/smrv.1999.0069_RF172","first-page":"414","article-title":"Sulipride, D2\/D3 antagonist, suppresses cataplexy, but has no effect on REM sleep in the canine narcolepsy model","volume":"2(S)","author":"Okura","year":"1999","journal-title":"Sleep Research Online"},{"key":"10.1053\/smrv.1999.0069_RF173","first-page":"990","article-title":"Kurz- und Langzeiteffekte von Sulpirid auf das nachtschlaf-EEG des Menschen","volume":"24","author":"Schneider","year":"1974","journal-title":"Arzneim.-Forsch"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079299900692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079299900692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T04:52:23Z","timestamp":1682139143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079299900692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":173,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["S1087079299900692"],"URL":"https:\/\/doi.org\/10.1053\/smrv.1999.0069","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}